2020
DOI: 10.5935/0004-2749.20200043
|View full text |Cite
|
Sign up to set email alerts
|

Clinical outcomes of ocular surface in patients treated with vitamin D oral replacement

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

1
11
0
4

Year Published

2021
2021
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 13 publications
(16 citation statements)
references
References 0 publications
1
11
0
4
Order By: Relevance
“…Previous studies have demonstrated a relationship between deficient levels of vitamin D and onset or development of AMD [ 16 , 21 , 22 , 23 , 24 , 25 , 26 , 27 , 28 , 29 , 30 ], suggesting that vitamin D administration can be protective or preventive from progression to neovascular AMD. Recent studies have reported expression of vitamin D receptors throughout the eye, including the retina [ 31 , 32 ], where they are expressed by human retinal pigment epithelial cells (ARPE-19) [ 31 , 33 ] and retinal endothelial cells [ 34 ], suggesting vitamin D’s functional significance in the ocular system [ 35 ].…”
Section: Introductionmentioning
confidence: 99%
“…Previous studies have demonstrated a relationship between deficient levels of vitamin D and onset or development of AMD [ 16 , 21 , 22 , 23 , 24 , 25 , 26 , 27 , 28 , 29 , 30 ], suggesting that vitamin D administration can be protective or preventive from progression to neovascular AMD. Recent studies have reported expression of vitamin D receptors throughout the eye, including the retina [ 31 , 32 ], where they are expressed by human retinal pigment epithelial cells (ARPE-19) [ 31 , 33 ] and retinal endothelial cells [ 34 ], suggesting vitamin D’s functional significance in the ocular system [ 35 ].…”
Section: Introductionmentioning
confidence: 99%
“…A previous case study reported that oral vitamin D supplementation ameliorated persistent symptoms in a 40-year-old patient with ocular pain, bilateral MGD, evaporative dry eye, and vitamin D deficiency [58]. A single-arm clinical study of 40 patients with vitamin D deficiency found that oral vitamin D supplementation for 8 weeks improved meibomian gland expressibility, eyelid margin condition, Schirmer's test value, FBUT, and subjective symptoms compared with baseline [19]. Eightweek topical application of an analog of the active form of vitamin D3 was also found to be associated with improved ocular symptoms, plugging and vascularity of lid margins, FBUT, corneal fluorescein staining, meibum grade, and meibomian gland area in patients with obstructive MGD [18].…”
Section: Discussionmentioning
confidence: 95%
“…Topical application of an analog of the active form of vitamin D3 was shown to ameliorate ocular symptoms and objective signs of MGD compared with baseline [18]. Oral vitamin D supplementation was also found to improve meibomian gland expressibility in MGD patients with vitamin D deficiency [19]. As far as we are aware, however, no observational study has previously examined the relationship between dietary intake of vitamin D and MGD.…”
Section: Introductionmentioning
confidence: 99%
“…27 Liu et al 21 suggested measuring the serum Vit-D levels for these patients and treating the Vit-D deficiency to prevent clinical and subclinical manifestations on the ocular surface. Karaca et al 28 reported an improvement in the functioning of the meibomian gland, the eyelid margin, Schirmer test measurement, TBUT, as well as subjective symptoms after 8 weeks of orally administered Vit-D supplementation in patients who had Vit-D deficiency. Bae et al 29 reported that an intramuscular injection of Vit-D in patients who have Vit-D deficiency improved the tear film parameters, including the TBUT, ocular surface staining, tear secretion, and lid margin hyperemia.…”
Section: Discussionmentioning
confidence: 99%